This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Imiquimod 3.75% cream, a topical medication, valued at $1,443.24. The award has an ultimate completion date of July 31, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award is for the delivery of Imiquimod 3.75% cream to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,701.27 and a completion date of June 15, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition....
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 3.75% Cream Pump, 7.5 gm. The order, valued at $1,302.82, has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,927.82 firm fixed price delivery order is for the supply of Imiquimod 3.75% Cream Pump 7.5gm, with a completion date of November 18, 2024. This award is not designated under a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of IMIQUIMOD 3.75% CREAM 28S to the Defense Logistics Agency (DLA), a defense agency. The $1,952.21 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imiquimod 3.75% Cream Pump in 7.5 gm containers. The contract has a ceiling value of $2,128.84 and a completion date of July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical...
This federal contract award, valued at $1,209.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imiquimod 3.75% Cream 28S, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imiquimod 5% Cream Packets 24s. The contract, valued at $1,726.61, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $1,847.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Imiquimod 3.75% cream, a dermatological medication. This is a firm fixed-price delivery order contract with a completion date of March 27, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award is for the delivery of Imiquimod 5% cream packets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $7,002.34, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...